Active Ingredient(s):Alpelisib FDA Approved: * April 5, 2022 Pharm Company: *NOVARTIS PHARMS CORP Category:Cancer
Alpelisib, sold under the brand name Piqray (as Pivikto in emerging markets), is a medication sold by Novartis and used to treat certain types of breast cancer. It is used together with fulvestrant. It is taken by mouth.it is indicated in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced ...
* May have multiple approval dates, manufacturers, or labelers.